Cary Street Partners Investment Advisory’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
Cary Street Partners Investment Advisory's OGN Position: Q2 2025 in Review
Cary Street Partners Investment Advisory sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 304 shares — an estimated $4.53K sold.
Cary Street Partners Investment Advisory first reported a position in OGN in Q4 2022 and held it in 7 quarters. The position peaked at $27.8K in Q4 2022. 695 funds tracked by Wall St. Rank hold OGN as of Q2 2025.
- Cary Street Partners Investment Advisory reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
- Cary Street Partners Investment Advisory sold 304 Organon & Co shares in Q2 2025, an estimated $4.53K.
- Cary Street Partners Investment Advisory first reported a position in Organon & Co in Q4 2022 and held it in 7 quarters.
- Cary Street Partners Investment Advisory's Organon & Co position peaked at $27.8K in Q4 2022.
- 695 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.
Based on Cary Street Partners Investment Advisory's 13F filing for Q2 2025, filed 13 Aug 2025.